Organization | St. Louis University

St. Louis University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: St. Louis MO United States (1818)

Organization Overview

First Clinical Trial

1983

NCT00000505

First Marketed Drug

2013

allogeneic hematopoietic stem cells (Hemacord)

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Cardinal Glennon Children's Hospital | Catherine Cibulskis, MD | Centre for Therapeutic Innovations in Oncology and Haematology / Saint Louis University Hospital | Saint Louis University | Saint Louis University Cardinal Glennon Children's Hospital | Saint Louis University Center for Vaccine Development, St. Louis, MO USA | Saint Louis University, Department of Internal Medicine, Division of Hematology and Oncology | Saint Louis University, Dept. of Internal Medicine, Div. of Hematology and Oncology | Saint Louis University Dermatology | Saint Louis University Hospital | Saint-Louis University, Saint-Louis, USA | Saint Louis University School of Medicine | Saint Louis University School of Medicine Department of Neurology and Psychiatry | Sandeep Singh Dhindsa, M.D., F.A.C.E | SSM Cardinal Glennon Children's Medical Center | St. Louis University | St. Louis University Dermatology | St. Louis University Hospital | St. Louis University Medical Center | St. Louis University School of Medicine | Tarek M. El-Achkar

Active Ingredients

Marketed Drugs (1)

allogeneic hematopoietic stem cells (Hemacord) (2013)

Drugs in Phase 4 Trials (17)

acetaminophen (tylenol) (3 trials)

cefazolin (ancef) (1 trial)

cephalexin (keflex) (1 trial)

clindamycin (cleocin) (1 trial)

fluticasone (cutivate) (1 trial)

gentamicin (garamycin) (1 trial)

inactivated influenza vaccine (3 trials)

lidocaine (xylocaine) (1 trial)

live attenuated influenza virus vaccine (Flumist) (1 trial)

methylphenidate (ritalin) (2 trials)

orlistat (xenical) (1 trial)

polyethylene glycol (1 trial)

povidone-iodine (betadine) (1 trial)

sodium oxybate (xyrem) (1 trial)

soybean oil (Intralipid) (1 trial)

sulfamethoxazole (gantanol) (1 trial)

trimethoprim (1 trial)

Drugs in Phase 3 Trials (28)

acetylsalicylic acid (aspirin) (1 trial)

alteplase (Activase) (1 trial)

amitriptyline (elavil) (1 trial)

atenolol (tenormin) (1 trial)

bifidobacterium infantis (1 trial)

clopidogrel (plavix) (2 trials)

diltiazem (cardizem) (1 trial)

escitalopram (lexapro) (2 trials)

hepatitis b immune globulin (human) (BayHep B) (1 trial)

hydrocodone (hycodan) (1 trial)

idursulfase (elaprase) (1 trial)

insulin human (humulin) (1 trial)

interferon alpha-2b (Intron-A) (2 trials)

isosorbide (isordil) (1 trial)

ketorolac (acuvail) (2 trials)

lactobacillus rhamnosus (1 trial)

lamivudine (epivir) (1 trial)

morphine (2 trials)

nifedipine (procardia) (2 trials)

oxycodone (oxycontin) (1 trial)

pioglitazone (actos) (3 trials)

pxt3003 (1 trial)

ribavirin (virazole) (2 trials)

secretin human (chirhostim) (1 trial)

sufonylurea (1 trial)

triamcinolone (kenalog) (1 trial)

zidovudine (retrovir) (1 trial)

zoledronic acid (zometa) (1 trial)

Drugs in Phase 2 Trials (29)

abciximab (Reopro) (1 trial)

aprepitant (Emend) (1 trial)

autologous hematopoietic stem cells (2 trials)

carboplatin (paraplatin) (2 trials)

clomifene (clomid) (1 trial)

cyclophosphamide (cytoxan) (2 trials)

daclizumab (Zenapax) (1 trial)

docetaxel (taxotere) (1 trial)

fentanyl (Innovar) (1 trial)

hydromorphone (diladid) (1 trial)

ibuprofen (motrin) (1 trial)

influenza ha antigen (1 trial)

larotaxel (1 trial)

lipo-5 (1 trial)

mesna (mesnex) (2 trials)

mifepristone (mifeprex) (1 trial)

modafinil (provigil) (1 trial)

mydicar (1 trial)

nitazoxanide (Alinia) (1 trial)

oxygen (1 trial)

paclitaxel (taxol) (2 trials)

pembrolizumab (keytruda) (1 trial)

progesterone (progestasert) (1 trial)

sargramostim (leukine) (2 trials)

testosterone (delatestryl) (1 trial)

trastuzumab (herceptin) (1 trial)

vcp1452 (1 trial)

vismodegib (erivedge) (1 trial)

Drugs in Phase 1 Trials (20)

adenosine (Adenocard) (1 trial)

aeras-422 (1 trial)

amoxicillin (1 trial)

bcg tice (1 trial)

belapectin (1 trial)

ep-1233 (1 trial)

ep hiv-1090 (1 trial)

huperzine a (1 trial)

influenza virus vaccine, intradermal (Fluzone) (1 trial)

melatonin (1 trial)

metformin (glucophage) (1 trial)

mva-mbn32 (1 trial)

nifurtimox (Lampit) (1 trial)

regadenoson (lexiscan) (1 trial)

rfpv-hiv (1 trial)

rmva-hiv (1 trial)

salmonella typhi vaccine (1 trial)

tat/rev/nef-rt (1 trial)

tbc-fpv (1 trial)

tbc-mva (1 trial)

Drugs in Other Trials (15)

chlorhexidine (hibitane) (1 trial)

codeine (Phenergan) (1 trial)

diphenhydramine (benadryl) (1 trial)

elemental gold (1 trial)

fish oil (Omegavan) (1 trial)

hydralazine (apresoline) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

ketoconazole (nizoral) (1 trial)

labetalol (trandate) (1 trial)

metoclopramide (reglan) (1 trial)

minocycline (minocin) (1 trial)

misoprostol (cytotec) (1 trial)

nortriptyline (aventyl) (1 trial)

pancrelipase (creon) (1 trial)

topiramate (topamax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Abscess (Phase 4)

Alzheimer Disease (Phase 4)

Anemia, Sickle Cell (Phase 2)

Asthma (Phase 4)

Birth Weight (Phase 3)

Body Weight (Phase 3)

Bone Neoplasms (Phase 3)

Brain Diseases (Phase 1)

Brain Ischemia (Phase 1)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Basal Cell (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Cardiomyopathies (Phase 2)

Cardiomyopathy, Dilated (Phase 2)

Cardiovascular Diseases (Phase 3)

Central Nervous System Neoplasms (Phase 2)

Charcot-Marie-Tooth Disease (Phase 3)

Cholestasis (Phase 4)

Chorioamnionitis (Phase 4)

Communicable Diseases (Phase 4)

Coronary Artery Disease (Phase 1)

Coronary Disease (Phase 3)

Cystic Fibrosis (Phase 4)

Dementia (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Digestive System Diseases (Phase 4)

Dyspepsia (Phase 3)

Endometritis (Phase 4)

Fatigue (Phase 2)

Fatty Liver (Phase 4)

Fibrosis (Phase 4)

Fistula (Phase 3)

Gastrointestinal Diseases (Phase 4)

Giant Cell Tumor of Bone (Phase 3)

Giant Cell Tumors (Phase 3)

Heart Diseases (Phase 3)

Heart Failure (Phase 2)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis C (Phase 3)

Hepatitis C, Chronic (Phase 3)

Hereditary Sensory and Motor Neuropathy (Phase 3)

HIV Infections (Phase 2)

Hyperemia (Phase 1)

Hypertension (Phase 1)

Hypogonadism (Phase 2)

Hypoxia (Phase 1)

Hypoxia-Ischemia, Brain (Phase 1)

Infarction (Phase 3)

Infections (Phase 4)

Inflammation (Phase 1)

Influenza, Human (Phase 4)

Insulin Resistance (Phase 3)

Ischemia (Phase 3)

Liver Cirrhosis (Phase 3)

Liver Cirrhosis, Biliary (Phase 3)

Melanoma (Phase 2)

Mucopolysaccharidoses (Phase 3)

Mucopolysaccharidosis II (Phase 3)

Multiple Myeloma (Phase 3)

Multiple Sclerosis (Phase 2)

Myocardial Infarction (Phase 3)

Myocardial Ischemia (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 2)

Nerve Compression Syndromes (Phase 3)

Nervous System Neoplasms (Phase 2)

Neuroblastoma (Phase 1)

Non-alcoholic Fatty Liver Disease (Phase 4)

Overweight (Phase 4)

Pain, Postoperative (Phase 4)

Pancreatic Diseases (Phase 3)

Pneumonia (Phase 1)

Recurrence (Phase 3)

Renal Insufficiency (Phase 3)

Sclerosis (Phase 2)

Skin Diseases (Phase 4)

Skin Diseases, Infectious (Phase 4)

Sleep Apnea, Obstructive (Phase 3)

Sleep Apnea Syndromes (Phase 3)

Sleepiness (Phase 2)

Syndrome (Phase 3)

Thrombosis (Phase 3)

Tooth Diseases (Phase 3)

Tuberculosis (Phase 1)

Virus Diseases (Phase 2)

Vomiting (Phase 2)

Overview

Highest Phase: Phase 4
# of Trials: 75
# of Trial APIs: 109